YM BioSciences (YM.TO) Completes Acquisition Of EXIMIAS Pharmaceutical Corporation
5/10/2006 10:58:42 AM
More...
|
Update - YM BioSciences (YM.TO) To Acquire EXIMIAS Pharmaceutical Corporation
4/17/2006 10:44:01 AM
More...
|
YM BioSciences (YM.TO) To Acquire EXIMIAS Pharmaceutical Corporation
4/13/2006 5:44:31 PM
More...
|
EXIMIAS Pharmaceutical Corporation Release: THYMITAQ(R) Completes Enrollment In Pivotal Phase III Liver Cancer Study
10/19/2005 5:13:08 PM
More...
|
EXIMIAS Pharmaceutical Corporation Appoints New CEO
10/19/2005 5:12:40 PM
More...
|
EXIMIAS Pharmaceutical Corporation Named Among Top 15 Emerging Biotech Companies Of 2004
10/19/2005 5:11:21 PM
More...
|
EXIMIAS Pharmaceutical Corporation Appoints Principal Investigators For THYMITAQ ETHECC Trial In Liver Cancer At Worldwide Investigators Meeting
10/19/2005 5:11:06 PM
More...
|
EXIMIAS Pharmaceutical Corporation Adds Three New Members To Management Team
10/19/2005 5:10:50 PM
More...
|
EXIMIAS Pharmaceutical Corporation To Present THYMITAQ(R) Highlights At Mid-Atlantic Venture Conference (MAVC) Biotechnology Industry Organization (BIO) VentureForum East Conference In Philadelphia On November 18
10/19/2005 5:10:46 PM
More...
|
EXIMIAS Pharmaceutical Corporation Announces $63.5 Million Private Placement
10/19/2005 5:10:39 PM
More...
|
|